198 related articles for article (PubMed ID: 26121143)
1. Proteomics and Transcriptomics of BJAB Cells Expressing the Epstein-Barr Virus Noncoding RNAs EBER1 and EBER2.
Pimienta G; Fok V; Haslip M; Nagy M; Takyar S; Steitz JA
PLoS One; 2015; 10(6):e0124638. PubMed ID: 26121143
[TBL] [Abstract][Full Text] [Related]
2. A Polymorphism in the Epstein-Barr Virus EBER2 Noncoding RNA Drives
Wang Y; Ungerleider N; Hoffman BA; Kara M; Farrell PJ; Flemington EK; Lee N; Tibbetts SA
mBio; 2022 Jun; 13(3):e0083622. PubMed ID: 35642944
[TBL] [Abstract][Full Text] [Related]
3. An EBNA3A-Mutated Epstein-Barr Virus Retains the Capacity for Lymphomagenesis in a Cord Blood-Humanized Mouse Model.
Romero-Masters JC; Ohashi M; Djavadian R; Eichelberg MR; Hayes M; Zumwalde NA; Bristol JA; Nelson SE; Ma S; Ranheim EA; Gumperz JE; Johannsen EC; Kenney SC
J Virol; 2020 May; 94(10):. PubMed ID: 32132242
[TBL] [Abstract][Full Text] [Related]
4. ZEB1 regulates the latent-lytic switch in infection by Epstein-Barr virus.
Yu X; Wang Z; Mertz JE
PLoS Pathog; 2007 Dec; 3(12):e194. PubMed ID: 18085824
[TBL] [Abstract][Full Text] [Related]
5. A Genome-Wide Epstein-Barr Virus Polyadenylation Map and Its Antisense RNA to EBNA.
Majerciak V; Yang W; Zheng J; Zhu J; Zheng ZM
J Virol; 2019 Jan; 93(2):. PubMed ID: 30355690
[TBL] [Abstract][Full Text] [Related]
6. Reactivation of Epstein-Barr Virus from Latency Involves Increased RNA Polymerase Activity at CTCF Binding Sites on the Viral Genome.
Dunn LEM; Lu F; Su C; Lieberman PM; Baines JD
J Virol; 2023 Feb; 97(2):e0189422. PubMed ID: 36744959
[TBL] [Abstract][Full Text] [Related]
7. Pseudouridylation of Epstein-Barr virus noncoding RNA EBER2 facilitates lytic replication.
Henry BA; Marchand V; Schlegel BT; Helm M; Motorin Y; Lee N
RNA; 2022 Nov; 28(11):1542-1552. PubMed ID: 36100352
[TBL] [Abstract][Full Text] [Related]
8. Unexpected patterns of Epstein-Barr virus transcription revealed by a high throughput PCR array for absolute quantification of viral mRNA.
Tierney RJ; Shannon-Lowe CD; Fitzsimmons L; Bell AI; Rowe M
Virology; 2015 Jan; 474():117-30. PubMed ID: 25463610
[TBL] [Abstract][Full Text] [Related]
9. Frequent traces of EBV infection in Hodgkin and non-Hodgkin lymphomas classified as EBV-negative by routine methods: expanding the landscape of EBV-related lymphomas.
Mundo L; Del Porro L; Granai M; Siciliano MC; Mancini V; Santi R; Marcar L; Vrzalikova K; Vergoni F; Di Stefano G; Schiavoni G; Segreto G; Onyango N; Nyagol JA; Amato T; Bellan C; Anagnostopoulos I; Falini B; Leoncini L; Tiacci E; Lazzi S
Mod Pathol; 2020 Dec; 33(12):2407-2421. PubMed ID: 32483241
[TBL] [Abstract][Full Text] [Related]
10. Targeting latent viral infection in EBV-associated lymphomas.
Kong IY; Giulino-Roth L
Front Immunol; 2024; 15():1342455. PubMed ID: 38464537
[TBL] [Abstract][Full Text] [Related]
11. Pathobiologic Roles of Epstein-Barr Virus-Encoded MicroRNAs in Human Lymphomas.
Navari M; Etebari M; Ibrahimi M; Leoncini L; Piccaluga PP
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29649101
[TBL] [Abstract][Full Text] [Related]
12. A multi-omics approach to Epstein-Barr virus immortalization of B-cells reveals EBNA1 chromatin pioneering activities targeting nucleotide metabolism.
Lamontagne RJ; Soldan SS; Su C; Wiedmer A; Won KJ; Lu F; Goldman AR; Wickramasinghe J; Tang HY; Speicher DW; Showe L; Kossenkov AV; Lieberman PM
PLoS Pathog; 2021 Jan; 17(1):e1009208. PubMed ID: 33497421
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic specifications of host chromosome docking sites for latent Epstein-Barr virus.
Kim KD; Tanizawa H; De Leo A; Vladimirova O; Kossenkov A; Lu F; Showe LC; Noma KI; Lieberman PM
Nat Commun; 2020 Feb; 11(1):877. PubMed ID: 32054837
[TBL] [Abstract][Full Text] [Related]
14. The expression and function of Epstein-Barr virus encoded latent genes.
Young LS; Dawson CW; Eliopoulos AG
Mol Pathol; 2000 Oct; 53(5):238-47. PubMed ID: 11091847
[TBL] [Abstract][Full Text] [Related]
15. Antitumor effects of duvelisib on Epstein-Barr virus-associated lymphoma cells.
Kawada JI; Ando S; Torii Y; Watanabe T; Sato Y; Ito Y; Kimura H
Cancer Med; 2018 Apr; 7(4):1275-1284. PubMed ID: 29522278
[TBL] [Abstract][Full Text] [Related]
16. Transcription profiling of Epstein-Barr virus nuclear antigen (EBNA)-1 expressing cells suggests targeting of chromatin remodeling complexes.
Sompallae R; Callegari S; Kamranvar SA; Masucci MG
PLoS One; 2010 Aug; 5(8):e12052. PubMed ID: 20706582
[TBL] [Abstract][Full Text] [Related]
17. Accurate Quantification of Overlapping Herpesvirus Transcripts from RNA Sequencing Data.
Casco A; Gupta A; Hayes M; Djavadian R; Ohashi M; Johannsen E
J Virol; 2022 Jan; 96(2):e0163521. PubMed ID: 34705568
[TBL] [Abstract][Full Text] [Related]
18. Nucleoside diphosphate kinase/Nm23 and Epstein-Barr virus.
Murakami M; Kaul R; Kumar P; Robertson ES
Mol Cell Biochem; 2009 Sep; 329(1-2):131-9. PubMed ID: 19412732
[TBL] [Abstract][Full Text] [Related]
19. The three-dimensional structure of the EBV genome plays a crucial role in regulating viral gene expression in EBVaGC.
Maestri D; Napoletani G; Kossenkov A; Preston-Alp S; Caruso LB; Tempera I
Nucleic Acids Res; 2023 Dec; 51(22):12092-12110. PubMed ID: 37889078
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr Virus Synergizes with BRD7 to Conquer c-Myc-Mediated Viral Latency Maintenance via Chromatin Remodeling.
Li S; Yang L; Li Y; Yue W; Xin S; Li J; Long S; Zhang W; Cao P; Lu J
Microbiol Spectr; 2023 Feb; 11(2):e0123722. PubMed ID: 36728436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
